{
    "2019-08-30": [
        [
            {
                "time": "",
                "original_text": "药明康德(02359)澄清涉及股东入股等媒体报道内容与事实情况不符",
                "features": {
                    "keywords": [
                        "药明康德",
                        "澄清",
                        "股东入股",
                        "媒体报道",
                        "事实不符"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)称：公司股本形成过程中不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股本形成",
                        "IPO",
                        "大股东",
                        "低价突击入股",
                        "不存在"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：不存在IPO之前大股东以不合理低价突击入股的情况",
                "features": {
                    "keywords": [
                        "药明康德",
                        "IPO",
                        "大股东",
                        "低价突击入股",
                        "不存在"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德澄清：不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
                "features": {
                    "keywords": [
                        "药明康德",
                        "澄清",
                        "IPO",
                        "大股东",
                        "低价突击入股",
                        "不存在"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "科技赋能传统医疗，药明康德参与惠每科技C轮3000万美元融资",
                "features": {
                    "keywords": [
                        "药明康德",
                        "科技赋能",
                        "传统医疗",
                        "惠每科技",
                        "融资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "外资最爱哪些股票？QFII最新重仓股来了！（附增减持排行榜）",
                "features": {
                    "keywords": [
                        "外资",
                        "QFII",
                        "重仓股",
                        "增减持排行榜"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:从“中国新”走向“全球新”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "周报",
                        "中国新",
                        "全球新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}